Technological innovation has triggered an unprecedented increase in data production in health research and healthcare. The need to make EU health research data FAIR (i.e., Findable, Accessible, Interoperable and Re-usable) becomes more pressing than ever before if European health research is to reap the full benefits of this valuable resource.
Professionals from across the country will come together to seek real answers on how to deliver closely integrated services, as the Joined Up Health and Care conference returns for its sixth year on 10th October at The Vox in Birmingham.
Health technology specialist IMS MAXIMS has been recognised for its innovative work in the UK and Irish healthcare market in the 2019 CV Business Innovator Awards. The company has been named as the leading innovator in healthcare administration software, in recognition of the quality of its patient administration system and electronic patient record solutions, which it provides to more than 180 healthcare organisations.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the commercial launch of Philips NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA).
The first Health Information Exchange (HIE) in the Middle East, Malaffi, went live at the end of July just six months after contracts were signed between the project company, Abu Dhabi Health Data Services (ADHDS), and technology provider Orion Health.
The availability of appropriate decision support tools for healthcare practitioners can promote uptake of personalised medicine in health care. There is a need to carry out research activities aiming to develop and validate such decision tools that would integrate available and/or emerging diagnostic means for the area concerned, enabling increased precision of diagnostics and clinical decision making.
| Location: | Zug, Rotkreuz, Switzerland |
| Job Type: | Full-Time |
| Employer: | Roche |
Commenting on findings and recommendations from Public Health England's review into dependence and withdrawal associated with some prescribed medicines, Darren Nichols, UK managing director, FDB (First Databank), said: